Aqualung Therapeutics Company

Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Technology: Other
Industry: P4 Medicine
Headquarters: Others
Founded Date: 2010-01-01
Employees Number: 1-10
Investors Number: 2
Total Funding: $19.8M
Last Funding Type: Grant

Visit Website
info@aqualungtherapeutics.com
Register and Claim Ownership